-
Single Antidepressant Dose of Intravenous Ketamine Safe
drugs
December 26, 2019
A single, low-dose ketamine infusion is relatively free of side effects for patients with treatment-resistant depression, according to research recently published in the Journal of Affective Disorders.
-
Access to High-Cost Targeted Treatments Varies for Lung Cancer
drugs
December 26, 2019
Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in the Journal of the National Cancer Institute.
-
Sosei Heptares Announces Clinical Start of Drug Discovery Collaboration with Pfizer
americanpharmaceuticalreview
December 24, 2019
Sosei Group has been notified by its strategic alliance partner Pfizer that it has dosed the first subject in a clinical trial with a new drug candidate nominated from the multi-target drug ...
-
Old drug offers new hope for children with devastating disorder
worldpharmanews
December 20, 2019
A drug that once helped obese adults lose weight, but was withdrawn from the market due to heart risks, may be safe and effective for children with a life-threatening seizure disorder called ...
-
FDA to Allow States to Import Prescription Drugs From Other Countries
drugs
December 19, 2019
Federal health officials have unveiled plans to allow prescription drug imports from Canada and other foreign nations.
-
Pelosi’s drug pricing bill passes House of Representatives
europeanpharmaceuticalreview
December 16, 2019
The House of Representatives has voted to approve Speaker Pelosi’s drug pricing bill in a Democrat-led chamber, say reports.
-
New drugs more likely to be approved if backed up by genetics, says study
europeanpharmaceuticalreview
December 16, 2019
A recent study has reported that a new drug candidate is more likely to be approved for use if it targets a gene known to be linked to the disease.
-
Multiple sclerosis drug market predicted to reach $32.9bn by 2028
europeanpharmaceuticalreview
December 12, 2019
Driven by the launch of various pipeline agents, a new report has projected that the multiple sclerosis therapeutics market will reach $32.9 billion in 2028.
-
Jubilant Biosys Expands Discovery Capabilities
ContractPharma
December 11, 2019
Begins major capacity expansions for its drug discovery services business.
-
Almac Awarded $200,000 BMGF Grant
ContractPharma
December 11, 2019
Will work to develop novel biocatalytic routes to Etonorgestrel and Levonorgestrel APIs.